MDNA Life Sciences

Executive Summary

MDNA Life Sciences is a San Diego-based biotechnology company developing non-invasive, blood-based diagnostic tests using its patented Mitomic™ Technology, which analyzes mitochondrial DNA (mtDNA) mutations for early cancer detection. Founded in 2001, the company focuses on providing highly accurate 'yes or no' answers to aid clinical decision-making and reduce unnecessary invasive procedures. Despite being private and early-stage, MDNA's technology holds promise for improving cancer screening, particularly in hard-to-detect cancers such as pancreatic or ovarian. The company has yet to commercialize a product, but its scientific approach addresses a significant unmet need in oncology diagnostics.

Upcoming Catalysts (preview)

• Q3 2026Completion of clinical validation study for pancreatic cancer detection60% success
• Q4 2026Strategic partnership with major diagnostic company45% success
• Q2 2026FDA breakthrough device designation application55% success